PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
SUMMARY: This activity will strengthen the Ministry of Health's (MOH) national laboratory network capacity
by continuing to provide technical assistance for multiple laboratory issues, including pediatric diagnostic
testing, quality assurance/quality control program (QA/QC), and selection and development of laboratory
information management system (LIMS). The Laboratory Technical Working Group at the Office of the
Global AIDS Coordinator (OGAC) led by CDC Global AIDS Program (GAP) International Laboratory Branch
and other United States Government (USG) senior staff recommends the use of DBS PCR (Amplicor
Deoxyribonucleic acid (DNA) PCR) testing for early infant diagnosis (EID). This recommendation was
endorsed by the World Health Organization (WHO) and the United Nations Children's Fund (UNICEF)/CDC
in May 2006. With funding provided by COP 08, DBS testing of infants has begun and will continue to
expand during COP 09.
ACTIVITY AND EXPECTED RESULTS:
Activity 1: This funding supports CDC/Haiti's full time, US direct hire (USDH) Laboratory Section Chief. This
is not a "new position" but rather a continuation of the hiring mechanism for the position. CDC Haiti recently
lost their Laboratory Section Chief, but recruiting efforts continue to find a replacement.
Activity 2: CDC Atlanta will continue to provide TA to the laboratory program of Haiti in order to help to
standardize laboratory program activities globally. Areas of expertise/evaluation will include selection of
laboratory methods for resource limited settings, TB testing, Laboratory Information Systems, viral load and
anti-retroviral resistance testing methods.
Activity 3: CDC Haiti will again support up to five national laboratory network staff for an external study tour
on maintenance and repair of automated and basic laboratory instruments. CDC will support the USG
laboratory team staff to travel within the country for supervisory visits, and to monitor and evaluate the
progress of the program. Given the weak human capacity in clinical laboratory science, CDC/Haiti
recognizes the value of hands-on learning gained through site visits to laboratories with similar conditions.
New/Continuing Activity: Continuing Activity
Continuing Activity: 17240
Continued Associated Activity Information
Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds
System ID System ID
17240 9923.08 HHS/Centers for US Centers for 7701 3141.08 $150,000
Disease Control & Disease Control
Prevention and Prevention
9923 9923.07 HHS/Centers for US Centers for 5154 3141.07 $298,000
Table 3.3.16:
